Kadimastem enters strategic collaboration with TargetGene to advance next-generation gene-edited cell therapies: Zurich, Switzerland Tuesday, October 28, 2025, 13:00 Hrs [IST] NLS ...
A University of Missouri-led discovery could pave the way for improved diagnosis and treatment of unexplained movement ...
To enhance and accelerate regulatory dialogue with the FDA To provide strategic guidance across clinical development programsTo bring deep expertise in CNS and immuno-oncology MADRID and CAMBRIDGE, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback